Investigation of nanoemulsion system for transdermal delivery of glibenclamide

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 4, 2012, Pages 482-487

  Wais, Mohammad ^a,c   Samad, Abdus ^b   Khale, Anubha ^c   Aqil, Mohd ^d   Khan, Mohib ^e  

^a NIMS UNIVERSITY   (India)

^b Fortis Clinical Research Ltd   (India)

^c HK College of Pharmacy   (India)

^d HAMDARD UNIVERSITY   (India)

^e ORIENTAL COLLEGE OF PHARMACY   (India)

Author keywords

Glibenclamide; Nanoemulsions; Pseudo ternary phase diagrams; Transdermal delivery

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; GLIBENCLAMIDE; POLYSORBATE 80;

ARTICLE; DRUG FORMULATION; DRUG PENETRATION; NANOEMULSION; TRANSDERMAL DRUG ADMINISTRATION; VISCOSITY;

EID: 84870862264     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Tenjarla S. Microemulsions: an overview and pharmaceutical applications: Crit Rev. Ther. Drug Carrier Syst. 1999; 16: 46-521.
2. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin AT. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 2005; 288: 27-34.
3. Maghraby GMEL. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int. J. Pharm. 2008; 355: 285-292.
4. Sintov CA, Shapiro L. New microemulsion vehicle facilitates percutenous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control Release. 2004; 95: 173-183.
5. Dixit N, Kohli K, Baboota, S. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug. PDA J. Pharm. Sci. Technol. 2008: 62: 46-55.
6. Khandavilli S, Panchagnula R. Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J. Invest. Dermatol. 2007; 127: 154-162.
7. Shevachman M, Garti N, Shani A, Sintov AC. Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev. Ind. Pharm. 2008; 34: 403-412.
8. Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F. Development and evaluation of a nanoemulsion formulation for transdermal delivery of terbinafine PDA. J. Pharm. Sci. Technol. 2007; 61: 276-285.
9. Kantarci G, Ozgüey I, Karasulu HY, Arzik, S, Güeri T. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. AAPS Pharm. Sci. Tech., 2007; 8: E 91.
10. Huang YB, Lin YH, Lu TM, Wang RJ, Tsai YH, Wu PC. Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int. J. Pharm. 2008; 349: 206-211.
11. Junyaprasert VB, Boonsaner P, Leatwimonlak S, Boonme P. Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1- butanol microemulsions. Drug Dev. Ind. Pharm. 2007; 33: 874-880.
12. Junyaprasert VB, Boonme P, Songkro S, Krauel K, Rades T. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions. J. Pharm. Pharm. Sci. 2007; 10: 288-298.
13. Kamal MA, Iimura N, Nabekura T, Kitagawa S. Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion. Chem. Pharm. Bull. 2007; 55:368-371.
14. Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm. Res. 2003; 20:264-269.
15. Yuan JS, Ansari M, Samaan M, Acosta EJ. Linker-based lecithin microemulsions for transdermal delivery of lidocaine. Int. J. Pharm. 2008; 349: 130-143.
16. Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int. J. Pharm. 2006; 321: 117-123.
17. Biruss B, Kahlig H, Valenta C. Evaluation of eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int. J. Pharm. 2007; 328: 142-151.
18. Shevachman M, Garti N, Shani A, Sintov AC. Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev. Ind. Pharm. 2008;34:403-412.
19. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac. AAPS Pharmaceutical Science and Technology. 2007; 8(4): E104.
20. Ambade KW, Jadhav SL, Gambhire MN, Kurmi SD, Kadam VJ, Jadhav KR. Formulation and evaluation of flurbiprofen microemulsion. Curr. Drug Deliv. 2008; 5:32-41.
21. Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm. 2006; 327: 58-64.
22. Paolino D, Ventura CA, Nisticó, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int. J. Pharm. 2002; 244:21-31.
23. Sintov, AC Botner S. Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int. J. Pharm. 2006; 311, 55.
24. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. In The Pharmacological Basis of Therapeutics, 9th Ed.; Gilman, A.G., Ed.; McGraw Hill: New York, 1996; 1487-1518.
25. Ishida M, Nambu N, Vagai T. Highly viscous gel ointment containing carbopol for application to the oral mucosa. Chem Pharm Bull. 1983; 31: 4561-4564.
26. Dollery C. Ed. Therapeutic drugs, Churchill Livington: Edinburgh; 1999. D196-D201.
27. Guy RH, Hadgraft J. In Transdermal drug delivery, developmental issues and research initiatives. Eds; Marcel Dekker: New York, 1990; pp. 59-68.
28. Gorus FK, Schuit FC, Intveld PA. Interaction of sulfonyl ureas with pancreatic beta cells-A study with gliburide. Diabetes. 1988; 37:1090-1095.
29. Ikegami H, Shima K, Tanaka A, Tahara Y, Hirota M, Kumahara Y. Interindividual variation in the absorption of glibenclamide in man. Acta Endocrinol Copenh.1986; 111: 528-532.
30. Chen H, Chang X, Weng T, Du D, Li J, Xu H, Yang X. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm. 2006; 315: 52-58.
31. Faiyaz S, Shafiq S, Sushma T, Farhan J, Khar R, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation, Eur. J. Pharm. Biopharm. 2007; 66: 227- 243.
32. Saranya S, Chandrasekaran N, Amitava M. Antibacterial activity of eucalyptus oil nanoemulsion against Proteus Mirabilis. Int J Pharm Pharm Sci. 2012; 4: 668-671.
33. Attwood D, Mallon C, Ktistis G, Taylor CJ. A study on factors influencing the droplet size in nonionic oil-in-water microemulsions. Int J Pharm. 1992; 88: 417-422.
34. Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI. Microemulsions: A novel Approach to Enhanced Drug Delivery. Recent Patents on Drug Delivery and formulation. 2008; 2: 238-257.
35. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J. Control Release. 2002; 81: 65-74.
36. Jignesh DM, Jayvadan KP. Nanoemulsion-Based Gel Formulation of Aceclofenac for Topical Delivery. Int J Pharm Pharm Sci. 2011; 1: 6-12.
37. Gao Z, Choi H, Shin H, Park K, Lim S, Hwang K, Kim C. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int J Pharm. 1998; 161: 75-86.
38. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 2000; 45: 89-121.
39. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. Design, development and evaluation of novel nanoemulsion formulation for transdermal potential of celecoxib. Acta Pharm. 2007; 57: 315-332.